공복혈당장애의 기준 하한치에 관한 코호트연구 - 일개병원 종합건강자료를 중심으로 -

What will be the Proper Criteria for Impaired Fasting Glucose for Korean Men? - Based on Medical Screening Data from a General Hospital -

  • 류승호 (성균관의대 강북삼성병원 산업의학과, 종합검진센터) ;
  • 김동일 (성균관의대 강북삼성병원 산업의학과) ;
  • 서병성 (성균관의대 강북삼성병원 산업의학과) ;
  • 김원술 (성균관의대 강북삼성병원 산업의학과, 종합검진센터) ;
  • 장유수 (성균관의대 강북삼성병원 종합검진센터)
  • Ryu, Seung-Ho (Department of Occupational Medicine, Health Screening Center, Kangbuk Samsung Hospital & Sungkyunkwan University) ;
  • Kim, Dong-Il (Department of Occupational Medicine, Kangbuk Samsung Hospital & Sungkyunkwan University) ;
  • Suh, Byung-Seong (Department of Occupational Medicine, Kangbuk Samsung Hospital & Sungkyunkwan University) ;
  • Kim, Woon-Sool (Department of Occupational Medicine, Health Screening Center, Kangbuk Samsung Hospital & Sungkyunkwan University) ;
  • Chang, Yoo-Soo (Health Screening Center, Kangbuk Samsung Hospital & Sungkyunkwan University)
  • 발행 : 2005.06.01

초록

Objectives: Recently, the American Diabetes Association (ADA) redefined the criteria of prediabetes, which has lowered the diagnostic level of fasting plasma glucose (FPG) from 110 to 125 mg/dl, down to levels between 100 to 125mg/dl. The purpose of this study was to determine the predictive cutoff level of FPG as a risk for the development of diabetes mellitus in Korean men. Methods: A retrospective cohort study was conducted on 11,423 (64.5%) out of 17,696 males $\leq$30 years of age, and who met the FPG of $\leq$125 mg/dl and hemoglobin A1c of $\leq$ 6.4% criteria, without a history of diabetes, and who were enrolled at the screening center of a certain university hospital between January and December 1999. The subjects were followed from January 1999 to December 2002 (mean follow-up duration; 2.3(${\pm}0.7$) years). They were classified as normal (FPG <100mg/dl), high glucose (FPG $\geq$100mg/dl and <110mg/dl) and impaired fasting glucose (FPG $\geq$110mg/dl and $\leq$125mg/dl) on the basis of their fasting plasma glucose level measured in 1999. We compared the incidence of diabetes between the 3 groups by performing Cox proportional hazards model and used receiver operating characteristic analyses of the FPG level, in order to estimate the optimal cut-off values as predictors of incident diabetes. Results: At the baseline, most of the study subjects were in age in their 30s to 40s (mean age, 41.8(${\pm}7.1$) year). The incidence of diabetes mellitus in this study was 1.19 per 1,000 person-years (95% CI=0.68-1.79), which was much lower than the results of a community-based study that was 5.01 per 1,000 person-years. The relative risks of incident diabetes in the high glucose and impaired fasting glucose groups, compared with the normal glucose group, were 10.3 (95% CI=2.58-41.2) and 95.2 (95% CI= 29.3-309.1), respectively. After adjustment for age, body mass index, and log triglyceride, a FPG greater than 100mg/dl remained significant predictors of incident diabetes. Using the receiver operating characteristic (ROC) curve, the optimal cutoff level of FPG as a predictor of incident diabetes was 97.5 mg/dl, with a sensitivity and a specificity of 81.0% and 86.0%, respectively. Conclusion: These results suggest that lowering the criteria of impaired fasting glucose is needed in Korean male adults. Future studies on community-based populations, including women, will be required to determine the optimal cutoff level of FPG as a predictor of incident diabetes.

키워드

참고문헌

  1. Expert committee on the diagnosis and classification of diabetes mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20: 1183-1197
  2. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications; report of a WHO consultation. Part I: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999
  3. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26(11): 3160-3167 https://doi.org/10.2337/diacare.26.11.3160
  4. Gabir MM, Hanson RL, Dabclea D, Imperatore G, Roumain J, Bennett PH, Knowler WC. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000; 23(8): 1108-1112 https://doi.org/10.2337/diacare.23.8.1108
  5. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperin-sulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113(12): 909-915 https://doi.org/10.7326/0003-4819-113-12-909
  6. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two-step model for development of non-insulin-dependent diabetes. Am J Med. 1991; 90(2): 229-235
  7. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992; 340(8825): 925-9 https://doi.org/10.1016/0140-6736(92)92814-V
  8. Kim HK, Park KS, Shin CS, Kim SY, Cho BY, Lee HK, Koh CS, Oh TG. Measurement of insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Korean Diabetes Assoc 1995; 18(19): 374-383 (Korean)
  9. Kim YI, Choi CS, Kim SW, Kim HK, Kim CH, Park JY, Hong SK, Lee KU. Changes in serum true insulin and C-peptide levels during oral glucose tolerance test in Koreans with glucose intolerance. J Korean Diabetes Assoc. 1998; 22: 192-198 (Korean)
  10. Shin CS, Lee HK, Koh CS, Kim YI, Shin YS, Yoo KY, Paik HY, Park YS, Yang BG. Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Core 1997: 20(12): 1842-1846 https://doi.org/10.2337/diacare.20.12.1842
  11. World Health Organization. Measuring obesity: classification and description of anthrommetric data. Copenhagen: WHO, 1989
  12. Expert commluee on the diagnosis and classification of diabetes mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197
  13. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P. Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish diabetes prevention study group. prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18). 1343-1350 https://doi.org/10.1056/NEJM200105033441801
  14. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6): 393-403 https://doi.org/10.1056/NEJMoa012512
  15. Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD, Ddbs A, Polak JF. Savage PJ. Cardiovascular disease in older adults with glucose disorders: comparison of American diabetes association criteria for diabetes mellitus with WHO criteria. Lancet 1999 21; 354(9179): 622-625
  16. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The funagata diabetes study. Diabetes Care. 1999; 22(6): 920-924 https://doi.org/10.2337/diacare.22.6.920
  17. Kim DH, Ahn YO, Park SW, Choi MG, Kim DS, Lee MS, Shin MH, Bae JM. Incidence and risk factors for diabetes mellitus in Korean middle-aged men: Seoul cohort DM follow-up study. Korean J Prev Med. 1999; 32(4): 526-537 (Korean)